Total Voting Rights & Admission to Trading

Summary by AI BETAClose X

Iconic Labs PLC has announced that as of 30 September 2026, its total voting rights stand at 17,628,165, based on its issued share capital of 17,628,165 Ordinary Shares. This figure should be used by shareholders for notification purposes under FCA rules. Additionally, 420,168 new Ordinary Shares were admitted to trading on the London Stock Exchange's Main Market on 17 September 2026, and these shares are fully fungible with existing Ordinary Shares.

Disclaimer*

Iconic Labs PLC
30 September 2026
 

Iconic Labs PLC

("Iconic" or the "Company")

Total Voting Rights & Admission to Trading

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rules, as at 30 September 2026, the Company's issued share capital consists of 17,628,165 Ordinary Shares of £0.0001, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 17,628,165.

The above figure of 17,628,165 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Admission to Trading

In accordance with the Financial Conduct Authority's Prospectus Rules, Iconic announces that 420,168 new Ordinary Shares in the Company were admitted to trading on the Main Market of the London Stock Exchange on 17 September 2026.

1)

Name and LEI

Iconic Labs PLC

213800YCXZV6RSHGGT04

2)

Regulated Market

London Stock Exchange - Main Market

3)

Name, type and ISIN

Ordinary Shares of £0.0001 each

ISIN: GB00BRBJ3P08

4)

Number of further securities issued and admitted

420,168

5)

Total number of securities in issue following admission

17,628,165

6)

Fungibility

Fully fungible with existing Ordinary Shares

7)

Dates of Admission

17 September 2026

8)

Prospectus Information

N/A

 

 

--ENDS--

 

For any further information or enquiries please contact:

Iconic Labs

John Farquharson, Chief Executive Officer

via Yellow Jersey PR

AlbR Capital Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7469 0930

 

Yellow Jersey PR

Charles Goodwin

Annabelle Wills

 

Tel: +44 (0) 20 3004 9512

 

iconic@yellowjerseypr.com

 






 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Iconic Labs (ICON)
UK 100

Latest directors dealings